115 filings
Page 2 of 6
8-K
56z8iooszlc6u4y2l3
9 May 23
Regulation FD Disclosure
9:12am
EFFECT
kvmu 8n8dxmix
4 May 23
Notice of effectiveness
12:15am
ARS
xom dttgnyzhh
1 May 23
Annual report to shareholders
4:41pm
DEFA14A
krvhbwcwlcnnl
1 May 23
Additional proxy soliciting materials
4:35pm
CORRESP
c1y7o52
1 May 23
Correspondence with SEC
12:00am
UPLOAD
o2f u95r3
24 Apr 23
Letter from SEC
12:00am
8-K
wvp4jy02b86
23 Mar 23
ARS Pharmaceuticals Highlights Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
4:09pm
8-K
q1hra1tuhno80tpne uy
13 Mar 23
Regulation FD Disclosure
9:26am
8-K
tcifzx1qwidx r5
22 Feb 23
Entry into a Material Definitive Agreement
4:11pm
8-K
fwbryb5gj9b009n
14 Feb 23
Results of Operations and Financial Condition
6:12am
8-K/A
yn71cdyzwgfjahdf
17 Jan 23
Report of Independent Registered Public Accounting Firm
5:06pm
S-8
d6k 6exgb
17 Jan 23
Registration of securities for employees
4:30pm
8-K
jtxw5g5mrfd0g38m 2kd
9 Dec 22
Departure of Directors or Certain Officers
5:02pm
8-K
tv3ktujlpds82vl5ul7l
6 Dec 22
Regulation FD Disclosure
5:07pm
8-K
0hydwh075hbgx6v 1ba7
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
DEFA14A
chsopoarji1an4x
2 Nov 22
Additional proxy soliciting materials
6:09am